PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial
SQZDelisted Stock | USD 0.10 0.04 28.57% |
Slightly above 62% of Sqz Biotechnologies' investor base is looking to short. The analysis of current outlook of investing in Sqz Biotechnologies Co suggests that many traders are alarmed regarding Sqz Biotechnologies' prospects. Sqz Biotechnologies' investing sentiment can be driven by a variety of factors including economic data, Sqz Biotechnologies' earnings reports, geopolitical events, and overall market trends.
Sqz |
Enrollment on track in registrational Phase 2 portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type advanced solid tumors more than 75 percent of sites activated across the U.S., Europe, and Asia-Pacific interim analysis expected by mid-2025 Dose-limiting toxicities observed in rezatapopt and Mercks anti-PD-1 therapy KEYTRUDA combination arm of Phase 1b PYNNACLE trial rezatapopt 500 mg once-daily in combination with pe
Read at finance.yahoo.com
Sqz Biotechnologies Fundamental Analysis
We analyze Sqz Biotechnologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sqz Biotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sqz Biotechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Sqz Biotechnologies is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Sqz Biotechnologies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sqz Biotechnologies stock to make a market-neutral strategy. Peer analysis of Sqz Biotechnologies could also be used in its relative valuation, which is a method of valuing Sqz Biotechnologies by comparing valuation metrics with similar companies.
Peers
Sqz Biotechnologies Related Equities
ANTX | AN2 Therapeutics | 21.90 | ||||
PCSA | Processa Pharmaceuticals | 18.37 | ||||
MNPR | Monopar Therapeutics | 8.84 | ||||
IKT | Inhibikase Therapeutics | 6.96 | ||||
LIPO | Lipella Pharmaceuticals | 5.42 | ||||
QNRX | Quoin Pharmaceuticals | 1.69 | ||||
HOWL | Werewolf Therapeutics | 1.52 | ||||
PMVP | Pmv Pharmaceuticals | 1.25 | ||||
KZR | Kezar Life | 0.95 | ||||
SNTI | Senti Biosciences | 0.93 | ||||
FENC | Fennec Pharmaceuticals | 0.83 | ||||
ANEB | Anebulo Pharmaceuticals | 0.70 | ||||
NUVB | Nuvation Bio | 0.35 | ||||
SABS | SAB Biotherapeutics | 1.02 | ||||
THRD | Third Harmonic | 2.67 | ||||
CADL | Candel Therapeutics | 4.85 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Sqz Stock
If you are still planning to invest in Sqz Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sqz Biotechnologies' history and understand the potential risks before investing.
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |